Beasley, Allen, Crow, Methvin, Portis and Miles, P.C. V. The Smith Law Firm, PLLC et al (LEAD)

  1. February 03, 2025

    Law Firm Involved In Talc Fee Fight Seeks To Arbitrate Claim

    The Smith Law Firm PLLC is urging an Alabama federal judge to compel arbitration of a cross-claim that Porter Malouf brought against it amid a lawsuit over an agreement the two firms and the Beasley Allen Law Firm entered to represent plaintiffs in litigation over Johnson & Johnson's tainted talcum powder.

  2. January 03, 2025

    Ala. Judge Won't Recuse In Talc Fight Due To Law Firm Work

    An Alabama federal judge will not recuse himself from a fight between two leading plaintiffs law firms in the multibillion-dollar litigation over Johnson & Johnson's tainted talcum powder, saying Friday that his previous representation of Beasley Allen Law Firm won't bias him against Smith Law Firm PLLC.

  3. December 20, 2024

    Beasley Allen Fights Bid To Recuse Judge In Talc Fee Suit

    Beasley Allen Law Firm on Friday fired back at The Smith Law Firm PLLC's motion to recuse an Alabama federal judge from Beasley Allen's breach of contract suit because the jurist previously represented the firm, arguing that the request is incompatible with Seventh Circuit precedent.

  4. December 18, 2024

    Talc Law Firm Seeks Judge's DQ In Beasley Allen Suit

    An Alabama federal judge's prior representation of Montgomery-based Beasley Allen Law Firm is grounds for The Smith Law Firm PLLC's motion filed Wednesday calling for the judge's recusal from Beasley Allen's breach of contract suit against the Smith firm regarding alleged owed expenses from a joint venture the two firms shared.

  5. September 12, 2024

    Beasley Sues Fellow Talc Firms Over Joint Venture Gone Awry

    Beasley Allen is going after its law firm partner in a joint venture that has represented thousands in talcum powder litigation against Johnson & Johnson, claiming in a new federal lawsuit that the firm is partially responsible for more than $1 million in owed expenses and, driven by its own financial woes, has unilaterally been negotiating with the pharmaceutical giant to the detriment of clients.